Britain builds the world's first AI biosecurity laboratory for £100m
OpenAI and Anthropic add up to £200m in technology to the government's £100m, DeepMind opens access to Gemini. A separate £65m goes to counter-pathogen measures.
Thanks for £1
Britain is building the world's first AI biosecurity laboratory: the government is putting £100m into an independent centre that will use frontier artificial intelligence models to detect biological threats — from new pathogens to risks created by AI itself. Let us be precise at once: this is about biological security, not cyber threats, as some retellings have claimed.
What the laboratory is
The centre is being set up as an independent non-profit where biologists work alongside frontier AI specialists. Its first tasks are to spot outbreaks and new pathogens earlier, strengthen disease surveillance and speed up the development and testing of vaccines and treatments. The state heavyweights are on board: the UK Health Security Agency, the Animal and Plant Health Agency and the defence laboratory Dstl, while the medicines regulator MHRA will work on rules for AI-designed medicine. The format is deliberately independent: the laboratory will belong neither to the state nor to the corporations, which should make data sharing between all participants easier.
Who provides the technology
The project's defining feature is the participation of the frontier model makers themselves. OpenAI is contributing up to £100m in computing power and model credits through its biodefense programme; Anthropic — also up to £100m in model credits, technology access and dedicated technical support. Google DeepMind joins the research and is working out trusted access to its Gemini and scientific models, while London-based Basecamp Research contributes its AI biology models. So the government's £100m is topped up by as much as £200m in kind from the AI developers.
Another £65m for countermeasures
The laboratory is part of a £165m National AI Biosecurity Initiative: a separate £65m goes to biological surveillance and the development of medical countermeasures against priority pathogens. The headquarters, timetable and scientific advisory board have not yet been named — those decisions are promised later.
Why it matters
The logic is twofold. On one hand, AI is dramatically accelerating biology — the same models that search for medicines could, in the wrong hands, help engineer a threat, and the state wants to see the risks first rather than read about them in the news. The pandemic priced a late start in weeks and trillions, so the bet now is on early detection. On the other, it is an industrial bet: Britain is strengthening its position as a global centre of safe AI, where regulators, universities and the developers' laboratories already work side by side. For readers it also means jobs: the project will need biologists, engineers and data specialists — we are watching the vacancies.
Thanks for £1If this information was useful and came in time, press the heart. Payment goes through PayPal, with nothing to choose and nothing to fill in, and it pays for the newsroom.
- Life Nemnogo Nervno’s Kateryna Gopenko plays London on 20 November
- Jobs & Business Post Your Ad Free
- Jobs & Business A ‘free office’ in London? Where you are welcome, with Wi-Fi and tea
- Books Book at bedtime: Pride and Prejudice and the price of a good match
- Life Russian-speaking doctors and clinics in London: eight addresses checked against the registers
- Immigration UK Standard Visitor Visa in 2026: Rules, Fees and Duration
- Travel Your first adult UK passport: £102, documents and timing in 2026


